News & Updates

Vedolizumab helps induce steroid-free remission in children with IBD
Vedolizumab helps induce steroid-free remission in children with IBD
21 May 2024 byStephen Padilla

Use of vedolizumab as maintenance treatment in children with inflammatory bowel disease (IBD) results in sustained steroid-free remission, with an acceptable safety profile, according to the results of the 54-week follow-up of the VedoKids Study presented at ESPGHAN 2024.

Vedolizumab helps induce steroid-free remission in children with IBD
21 May 2024
Infants, children with comorbidities at greatest risk for critical COVID-19
Infants, children with comorbidities at greatest risk for critical COVID-19
21 May 2024 byStephen Padilla

The risk of critical COVID-19 is highest among infants and adolescents, children with multiple comorbidities, those with a history of prematurity, diabetes, obesity, severe immunocompromise, and those with cardiovascular, neurologic, or chronic lung diseases, reveals a study presented at PAS 2024.

Infants, children with comorbidities at greatest risk for critical COVID-19
21 May 2024
Hypertension puts kids at risk of long-term cardiac events
Hypertension puts kids at risk of long-term cardiac events
20 May 2024 byStephen Padilla

Children who have hypertension are more likely to experience adverse cardiovascular outcomes in the future than those without high blood pressure (BP), according to a study presented at PAS 2024.

Hypertension puts kids at risk of long-term cardiac events
20 May 2024